CEACAM5 and neoplasm: In the clinical diagnosis of NSCLC, the presence of cytokeratin 19 fragments antigen (CYFRA21-1), carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) in the peripheral blood are used as reference tumor biomarkers.